News Industry News Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure October 27, 2015
News Industry News Symic Biomedical Advances First Product Candidate, SB-030, into Clinical Development with Treatment of First Patient in SHIELD Trial October 27, 2015
News Daily News Sin Dinero Ni Medicamentos: Barreras Globales a la Prevención Secundaria de la Enfermedad Cardiovascular Caitlin E. Cox October 27, 2015
News Industry News Amsel Medical Corporation Announces Filing of 2nd 510(k) Pre-Marketing Notification with the US Food and Drug Administration for the Amsel Occluder Device October 27, 2015
News Daily News No Money, No Drugs: Global Barriers to Secondary CVD Prevention Caitlin E. Cox October 27, 2015
News Daily News First NOAC Antidote, Idarucizumab, Approved; Likely Won’t Hold Up Interventions Todd Neale October 26, 2015
News Daily News Actualización de la Directriz Impulsa la PCI de la Arteria no Causante y Saca de la Pelea a la Trombectomía por Aspiración Todd Neale October 26, 2015
News Daily News Más Noticias Desalentadoras para los BRFs en el Tratamiento de Lesiones Infrapoplíteas L.A. McKeown October 26, 2015